These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 33452207)

  • 1. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition to a mesenchymal state in neuroblastoma may be characterized by a high expression of GD2 and by the acquisition of immune escape from NK cells.
    Di Matteo S; Bilotta MT; Pelosi A; Haas D; Theinert T; Weber G; Schlegel PG; Berg M; Moretta L; Maggi E; Azzarone B; Vacca P; Tumino N; Caruana I
    Front Immunol; 2024; 15():1382931. PubMed ID: 38736882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
    Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma Tumor-Associated Mesenchymal Stromal Cells Regulate the Cytolytic Functions of NK Cells.
    Di Matteo S; Avanzini MA; Pelizzo G; Calcaterra V; Croce S; Spaggiari GM; Theuer C; Zuccotti G; Moretta L; Pelosi A; Azzarone B
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human dental pulp stem cells regulate allogeneic NK cells' function via induction of anti-inflammatory purinergic signalling in activated NK cells.
    Yan F; Liu O; Zhang H; Zhou Y; Zhou D; Zhou Z; He Y; Tang Z; Wang S
    Cell Prolif; 2019 May; 52(3):e12595. PubMed ID: 30953394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
    Xu M; Shaw G; Murphy M; Barry F
    Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity.
    Johann PD; Vaegler M; Gieseke F; Mang P; Armeanu-Ebinger S; Kluba T; Handgretinger R; Müller I
    BMC Cancer; 2010 Sep; 10():501. PubMed ID: 20858262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
    Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
    Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity.
    Häusler SF; Montalbán del Barrio I; Strohschein J; Chandran PA; Engel JB; Hönig A; Ossadnik M; Horn E; Fischer B; Krockenberger M; Heuer S; Seida AA; Junker M; Kneitz H; Kloor D; Klotz KN; Dietl J; Wischhusen J
    Cancer Immunol Immunother; 2011 Oct; 60(10):1405-18. PubMed ID: 21638125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells.
    Hu CD; Kosaka Y; Marcus P; Rashedi I; Keating A
    Stem Cells Dev; 2019 Jul; 28(14):933-943. PubMed ID: 31122145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.
    Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S
    J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Experimental Study Comparing the Expansion of Peripheral Blood Natural Killer (NK) Cells Cultured with Artificial Antigen-Presenting Cells, in the Presence or Absence of Bone Marrow Mesenchymal Stem Cells (MSCs).
    Pedroso JF; de Souza Valim V; Pezzi A; Furlan JM; Lenhart G; Sehn F; Zambonato B; Gonçalves AD; Wilke I; Amorin B; da Silva MA; Pedrazzani FS; da Rocha Silla LM
    Mol Biotechnol; 2020 May; 62(5):306-315. PubMed ID: 32193710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance.
    Jain D; Somasundaram DB; Aravindan S; Yu Z; Baker A; Esmaeili A; Aravindan N
    Cell Biol Toxicol; 2023 Jun; 39(3):967-989. PubMed ID: 34773529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic targeting enhances immunotherapy of CD73
    Wang J; Lupo KB; Chambers AM; Matosevic S
    J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
    Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
    Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma.
    Seidel D; Shibina A; Siebert N; Wels WS; Reynolds CP; Huebener N; Lode HN
    Cancer Immunol Immunother; 2015 May; 64(5):621-34. PubMed ID: 25711293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
    Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
    Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dermis harbors distinct mesenchymal stromal cell subsets.
    Vaculik C; Schuster C; Bauer W; Iram N; Pfisterer K; Kramer G; Reinisch A; Strunk D; Elbe-Bürger A
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):563-74. PubMed ID: 22048731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.